UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing

Journal of hematology and oncology, 2018-12, Vol.11 (1), p.142-142, Article 142

2018

Volltextzugriff (PDF)

Increasing cure rates of solid tumors by immune checkpoint inhibitors

Experimental hematology & oncology, 2023-01, Vol.12 (1), p.10-10, Article 10

2023

Volltextzugriff (PDF)

Systemic Antitumor Effect of Intratumoral Injection of Dendritic Cells in Combination with Local Photodynamic Therapy

Clinical cancer research, 2006-04, Vol.12 (8), p.2568-2574

2006

Volltextzugriff (PDF)

Combined intratumoral injection of bone marrow-derived dendritic cells and systemic chemotherapy to treat pre-existing murine tumors

Cancer research (Chicago, Ill.), 2001-10, Vol.61 (20), p.7530-7535

2001

Volltextzugriff (PDF)

Proceedings of the 2016 China Cancer Immunotherapy Workshop

Journal of hematology and oncology, 2016-10, Vol.9 (1), p.1-8

2016

Volltextzugriff (PDF)

Marriage of Heterobuckybowls with Triptycene: Molecular Waterwheels for Separating C 60 and C 70

Chemistry : a European journal, 2022-04, Vol.28 (20), p.e202200306

2022

Volltextzugriff (PDF)

KP104, a Bifunctional C5 Antibody/Factor H Fusion Protein, Effectively Controls Both Intravascular and Extravascular Hemolysis: Interim Results from a Phase 2 Study in Complement Inhibitor-Naïve PNH Patients

Blood, 2023-11, Vol.142 (Supplement 1), p.572-572

2023

Volltextzugriff (PDF)

33 C5 cleavage inhibition combined with C3 convertase targeting protects from disease development in a preclinical model of autoimmune skin disease

Immunobiology (1979), 2023-09, Vol.228 (5), p.152487, Article 152487

2023

Volltextzugriff (PDF)

Opening two benzene rings on trichalcogenasumanenes toward high performance organic optical-limiting materials

Chemical communications (Cambridge, England), 2018, Vol.54 (78), p.10981-10984

2018

Volltextzugriff (PDF)

Marriage of Heterobuckybowls with Triptycene: Molecular Waterwheels for Separating C60 and C70

Chemistry : a European journal, 2022-04, Vol.28 (20), p.e202200306-n/a

2022

Volltextzugriff (PDF)

221 SYNERGY-1: A Phase 1, first-in-human, randomized, double-blind, placebo-controlled safety, tolerability, immunogenicity, PK and PD study of KP104 in escalating single and multiple doses

Immunobiology (1979), 2023-09, Vol.228 (5), p.152671, Article 152671

2023

Volltextzugriff (PDF)

Trial in Progress: An Open-Label, Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104 in Complement Inhibitor-Naïve Subjects with Paroxysmal Nocturnal Hemoglobinuria

Blood, 2022-11, Vol.140 (Supplement 1), p.11459-11460

2022

Volltextzugriff (PDF)

SYNERGY-1: A Phase 1, First-in-Human, Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics Study of KP104 in Escalating Single and Multiple Doses: SA-PO636

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.779-779

2022

Volltextzugriff (PDF)

Opening two benzene rings on trichalcogenasumanenes toward high performance organic optical-limiting materialsElectronic supplementary information (ESI) available: Synthetic details, characterization of the compounds, theoretical calculations, and additional optical spectra. See DOI: 10.1039/c8cc05480k

2018-09

Volltextzugriff (PDF)

Lymphoma Immunotherapy with CpG Oligodeoxynucleotides Requires TLR9 Either in the Host or in the Tumor Itself

Journal of Immunology, 2007-08, Vol.179 (4), p.2493-2500

2007

Volltextzugriff (PDF)

A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40

Journal of hematology and oncology, 2015-04, Vol.8 (1), p.35-35, Article 35

2015

Volltextzugriff (PDF)

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

The Journal of experimental medicine, 1997-10, Vol.186 (8), p.1247-1256

1997

Volltextzugriff (PDF)

Intermittent, repetitive corticosteroid-induced upregulation of platelet levels after adenovirus-mediated transfer to the liver of a chimeric glucocorticoid-responsive promoter controlling the thrombopoietin cDNA

Blood, 1998-08, Vol.92 (3), p.822-833

1998

Volltextzugriff (PDF)

CpG in the Immunotherapy of B-Cell Lymphoma

Blood, 2005-11, Vol.106 (11), p.344-344

2005

Volltextzugriff (PDF)

Proceedings of the 2016 China Cancer Immunotherapy Workshop: Beijing, China. 25-26 June 2016

Journal of hematology and oncology, 2016-10, Vol.9 (S1), Article 104

2016

Volltextzugriff (PDF)

Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats

Journal of Virology, 1992-09, Vol.66 (9), p.5409-5417

1992

Volltextzugriff (PDF)

P-108 光線力学的治療, ラジオ波焼灼療法と樹状細胞癌ワクチン療法の併用による相乗効果:前臨床研究と臨床応用

肺癌, 2006-11, Vol.46 (5), p.552-552

2006

Volltextzugriff (PDF)

Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor

Human gene therapy, 1998-04, Vol.9 (6), p.823-833

1998

Volltextzugriff (PDF)

Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy. Commentary

Clinical cancer research, 2006, Vol.12 (8), p.2568-2574

2006

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(102)
Dissertationen
(1)

Sprache

Englisch
(99)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing

Increasing cure rates of solid tumors by immune checkpoint inhibitors

Systemic Antitumor Effect of Intratumoral Injection of Dendritic Cells in Combination with Local Photodynamic Therapy

Combined intratumoral injection of bone marrow-derived dendritic cells and systemic chemotherapy to treat pre-existing murine tumors

Proceedings of the 2016 China Cancer Immunotherapy Workshop

Marriage of Heterobuckybowls with Triptycene: Molecular Waterwheels for Separating C 60 and C 70

KP104, a Bifunctional C5 Antibody/Factor H Fusion Protein, Effectively Controls Both Intravascular and Extravascular Hemolysis: Interim Results from a Phase 2 Study in Complement Inhibitor-Naïve PNH Patients

33 C5 cleavage inhibition combined with C3 convertase targeting protects from disease development in a preclinical model of autoimmune skin disease

Opening two benzene rings on trichalcogenasumanenes toward high performance organic optical-limiting materials

Marriage of Heterobuckybowls with Triptycene: Molecular Waterwheels for Separating C60 and C70

221 SYNERGY-1: A Phase 1, first-in-human, randomized, double-blind, placebo-controlled safety, tolerability, immunogenicity, PK and PD study of KP104 in escalating single and multiple doses

Trial in Progress: An Open-Label, Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104 in Complement Inhibitor-Naïve Subjects with Paroxysmal Nocturnal Hemoglobinuria

SYNERGY-1: A Phase 1, First-in-Human, Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics Study of KP104 in Escalating Single and Multiple Doses: SA-PO636

Lymphoma Immunotherapy with CpG Oligodeoxynucleotides Requires TLR9 Either in the Host or in the Tumor Itself

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

Intermittent, repetitive corticosteroid-induced upregulation of platelet levels after adenovirus-mediated transfer to the liver of a chimeric glucocorticoid-responsive promoter controlling the thrombopoietin cDNA

CpG in the Immunotherapy of B-Cell Lymphoma

Proceedings of the 2016 China Cancer Immunotherapy Workshop: Beijing, China. 25-26 June 2016

Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats

P-108 光線力学的治療, ラジオ波焼灼療法と樹状細胞癌ワクチン療法の併用による相乗効果:前臨床研究と臨床応用

Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor

Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy. Commentary

Aktive Filter

Suchergebnisse filtern